[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Avita Medical (AVMXY)

Avita Medical (AVMXY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Avita Medical 28159 Avenue Stanford Suite 220 Valencia CA 91355 USA

www.avitamedical.com P: 661-367-9170

Sector:

Medical

INDUSTRY GROUPING:

Medical - Hospitals

Description:

Avita Medical Limited operates as a medical technology company. The company develops and distributes products in Regenerative and Respiratory Medicine. Avita's regenerative and tissue-engineered products provide revolutionary solutions utilizing the patient's own skin and the regenerative capability of the human body to treat a wide range of wounds, scars and skin defects. The Company's lead product, ReCell(R) Spray'On Skin (R), is used in a wide variety of burns, plastic, reconstructive and cosmetic procedures. It manufactures and sells a range of spacers for the paediatric, adolescent and adult market. Avita Medical Limited is headquartered in Cambridge, the United Kingdom.

Key Statistics

Overview:

Market Capitalization, $K 651,880
Shares Outstanding, K 82,621
Float, K 82,621
% Float 100.00%
% of Institutional Shareholders 0.01%

Financials:

Annual Sales, $ 5,510 K
Annual Net Income, $ -24,750 K

Growth:

1-Year Return 385.84%
3-Year Return 330.96%
5-Year Return 348.30%
5-Year Revenue Growth 123.98%
5-Year Earnings Growth -34.48%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 12/31/69
Earnings Per Share ttm 0.00
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

AVMXY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -449.18%
Debt/Equity 0.00
Price/Sales 108.39
Price/Cash Flow N/A
Price/Book 29.98
Book Value/Share 0.26
Interest Coverage -828.33
60-Month Beta 1.28
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.